ANI PHARMACEUTICALS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for ANI PHARMACEUTICALS INC (ANIP), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are ANIP insiders buying or selling?
In the last 12 months, ANI PHARMACEUTICALS INC insiders reported 0 open-market purchases ($0) and 43 sales ($15.1M) — net selling of $15.1M. Since March 2018, Trabud has recorded 179 Form 4 filings for ANIP: 13 buys ($2.2M) and 166 sells ($182.3M).
Source: SEC EDGAR Form 4
What stands out
- No ANI PHARMACEUTICALS INC insider made an open-market purchase in the last 12 months; the 43 reported open-market sales totaled $15.1M.
Key Statistics (March 2018 – Oct 14, 2026)
Total Form 4 filings
179
SEC EDGAR
Insider filers
22
Insider buys (13)
$2.2M
Insider sells (166)
$182.3M
Insider sentiment
Net sellingNet insider flow of $180.0M in net selling since March 2018, and $15.1M in net selling over the last 12 months.
Recent ANIP insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $73.59 | $36.8K | SEC ↗ |
| Sep 30, 2026 | Stephen P. Carey | SVP & CFO | Sale | 2.9K | $73.00 | $208.1K | SEC ↗ |
| Sep 16, 2026 | Nikhil Lalwani | PRESIDENT & CEO | Sale | 5.4K | $71.00 | $383.4K | SEC ↗ |
| Sep 15, 2026 | Jeanne Thoma | Director | Sale | 1.0K | $71.53 | $71.5K | SEC ↗ |
| Sep 15, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $70.79 | $35.4K | SEC ↗ |
| Sep 1, 2026 | Stephen P. Carey | SVP & CFO | Sale | 2.9K | $72.80 | $207.5K | SEC ↗ |
| Aug 26, 2026 | Nikhil Lalwani | PRESIDENT & CEO | Sale | 5.4K | $74.30 | $401.2K | SEC ↗ |
| Aug 13, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $75.48 | $37.7K | SEC ↗ |
| Aug 12, 2026 | Ori Gutwerg | SVP, GENERICS | Sale | 3.2K | $77.00 | $243.5K | SEC ↗ |
| Jul 30, 2026 | Stephen P. Carey | SVP & CFO | Sale | 2.9K | $81.36 | $231.9K | SEC ↗ |
| Jul 14, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $81.84 | $40.9K | SEC ↗ |
| Jul 7, 2026 | Stephen P. Carey | SVP & CFO | Sale | 3.3K | $86.00 | $284.9K | SEC ↗ |
| Jun 30, 2026 | Stephen P. Carey | SVP & CFO | Sale | 2.9K | $84.12 | $239.7K | SEC ↗ |
| Jun 15, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $82.03 | $41.0K | SEC ↗ |
| Jun 11, 2026 | Thomas Haughey | Director | Sale | 2.0K | $80.88 | $161.8K | SEC ↗ |
| Jun 9, 2026 | Stephen P. Carey | SVP & CFO | Sale | 3.3K | $80.00 | $265.0K | SEC ↗ |
| May 14, 2026 | Patrick D Walsh | Director | Sale | 14.0K | $80.66 | $1.1M | SEC ↗ |
| May 13, 2026 | Thomas Andrew Rowland | SVP, HEAD - ESTABLISHED BRANDS | Sale | 459 | $79.21 | $36.4K | SEC ↗ |
| May 13, 2026 | Nikhil Lalwani | PRESIDENT & CEO | Sale | 55.0K | $77.57 | $4.3M | SEC ↗ |
| May 13, 2026 | Ori Gutwerg | SVP, GENERICS | Sale | 2.8K | $79.50 | $220.4K | SEC ↗ |
| May 13, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $78.16 | $39.1K | SEC ↗ |
| Apr 13, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $77.95 | $39.0K | SEC ↗ |
| Mar 13, 2026 | Thomas Andrew Rowland | SVP, HEAD - ESTABLISHED BRANDS | Sale | 4.8K | $74.91 | $357.5K | SEC ↗ |
| Mar 13, 2026 | Christopher Mutz | HEAD OF RARE DISEASE | Sale | 3.2K | $71.64 | $226.5K | SEC ↗ |
| Mar 13, 2026 | Meredith Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $72.62 | $36.3K | SEC ↗ |
Showing the 25 most recent of 179 Form 4 filings for ANI PHARMACEUTICALS INC.
Most active ANIP insiders
- Meredith Cook35 filings
- Muthusamy Shanmugam28 filings
- Chad Gassert13 filings
- Stephen P. Carey12 filings
- Krista Davis10 filings
Ask anything about ANIP insider activity
Use Trabud's AI agent to query ANI PHARMACEUTICALS INC's Form 4 history in plain English — "Show me ANIP CEO purchases this year" or compare it against any other ticker.
Open the AI agentANIP insider trading FAQ
Are ANI PHARMACEUTICALS INC insiders buying or selling?
In the last 12 months, ANI PHARMACEUTICALS INC insiders reported 0 open-market purchases ($0) and 43 sales ($15.1M) — net selling of $15.1M. Since March 2018, Trabud has recorded 179 Form 4 filings for ANIP: 13 buys ($2.2M) and 166 sells ($182.3M). Over the full record that is net selling of $180.0M.
How many insiders trade ANIP stock?
22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ANI PHARMACEUTICALS INC. The most recent filing was accepted on Oct 14, 2026.
Where does Trabud get ANIP insider trading data?
All ANIP insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.